Neuland Laboratories shares rose sharply on Thursday after the drugmaker reported a 975% year-on-year surge in Q1 FY27 profit to Rs 147.4 crore. Revenue more than doubled, while EBITDA jumped 448%, driven by strong commercial product sales and encouraging performance across its CMS and GDS businesses.
Neuland Laboratories shares rose sharply on Thursday after the drugmaker reported a 975% year-on-year surge in Q1 FY27 profit to Rs 147.4 crore. Revenue more than doubled, while EBITDA jumped 448%, driven by strong commercial product sales and encouraging performance across its CMS and GDS businesses.
<iframe src="https://hindustansphere.com/embed/cluster/1a95947dffe2aec4504a8e6092206435758e7151" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Neuland Laboratories shares jump over 6% after 975% YoY surge in Q1 profit"></iframe>
Shares of Neuland Laboratories rose over 6% to Rs 21,200 on the BSE on Thursday after the company reported a sharp jump in its June quarter earnings. Its profit after tax surged 975% year-on-year to Rs 147.4 crore in Q1 FY27, compared with Rs 13.7 crore a year ago.The company released its Q1 results in the post-market hours on Wednesday.Total income of the company stood at Rs 650.1 crore, up 116.3% from Rs 300.6 crore in the corresponding quarter of the previous year. The company’s EBITDA saw a…
